ARCOSA INC (ACA) Stock Fundamental Analysis

NYSE:ACA • US0396531008

109.96 USD
+1.34 (+1.23%)
Last: Mar 3, 2026, 03:20 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Taking everything into account, ACA scores 5 out of 10 in our fundamental rating. ACA was compared to 55 industry peers in the Construction & Engineering industry. ACA has an average financial health and profitability rating. ACA has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • ACA had positive earnings in the past year.
  • ACA had a positive operating cash flow in the past year.
  • ACA had positive earnings in 4 of the past 5 years.
  • ACA had a positive operating cash flow in 4 of the past 5 years.
ACA Yearly Net Income VS EBIT VS OCF VS FCFACA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

1.2 Ratios

  • The Return On Assets of ACA (2.94%) is comparable to the rest of the industry.
  • ACA has a Return On Equity (5.75%) which is comparable to the rest of the industry.
  • The Return On Invested Capital of ACA (4.99%) is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for ACA is significantly below the industry average of 17.06%.
  • The last Return On Invested Capital (4.99%) for ACA is above the 3 year average (3.99%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.94%
ROE 5.75%
ROIC 4.99%
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
ACA Yearly ROA, ROE, ROICACA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • ACA's Profit Margin of 5.25% is fine compared to the rest of the industry. ACA outperforms 61.82% of its industry peers.
  • In the last couple of years the Profit Margin of ACA has declined.
  • The Operating Margin of ACA (10.27%) is better than 69.09% of its industry peers.
  • ACA's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 21.61%, ACA is in the better half of the industry, outperforming 67.27% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ACA has remained more or less at the same level.
Industry RankSector Rank
OM 10.27%
PM (TTM) 5.25%
GM 21.61%
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
ACA Yearly Profit, Operating, Gross MarginsACA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • ACA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • ACA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ACA Yearly Shares OutstandingACA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ACA Yearly Total Debt VS Total AssetsACA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 2.43 indicates that ACA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.43, ACA is doing worse than 60.00% of the companies in the same industry.
  • ACA has a debt to FCF ratio of 5.03. This is a neutral value as ACA would need 5.03 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 5.03, ACA is doing good in the industry, outperforming 61.82% of the companies in the same industry.
  • A Debt/Equity ratio of 0.61 indicates that ACA is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.61, ACA is in line with its industry, outperforming 52.73% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 5.03
Altman-Z 2.43
ROIC/WACC0.53
WACC9.49%
ACA Yearly LT Debt VS Equity VS FCFACA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 2.02 indicates that ACA has no problem at all paying its short term obligations.
  • ACA's Current ratio of 2.02 is amongst the best of the industry. ACA outperforms 87.27% of its industry peers.
  • A Quick Ratio of 1.30 indicates that ACA should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.30, ACA is in line with its industry, outperforming 58.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 1.3
ACA Yearly Current Assets VS Current LiabilitesACA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 48.50% over the past year.
  • The Earnings Per Share has been growing by 12.78% on average over the past years. This is quite good.
EPS 1Y (TTM)48.5%
EPS 3Y26.66%
EPS 5Y12.78%
EPS Q2Q%150%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.58%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.17% on average over the next years. This is quite good.
  • Based on estimates for the next years, ACA will show a small growth in Revenue. The Revenue will grow by 5.28% on average per year.
EPS Next Y9.06%
EPS Next 2Y11.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.18%
Revenue Next 2Y5.28%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
ACA Yearly Revenue VS EstimatesACA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
ACA Yearly EPS VS EstimatesACA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 24.60 indicates a rather expensive valuation of ACA.
  • Based on the Price/Earnings ratio, ACA is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 27.13. ACA is around the same levels.
  • ACA is valuated rather expensively with a Price/Forward Earnings ratio of 22.56.
  • Based on the Price/Forward Earnings ratio, ACA is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of ACA to the average of the S&P500 Index (28.11), we can say ACA is valued inline with the index average.
Industry RankSector Rank
PE 24.6
Fwd PE 22.56
ACA Price Earnings VS Forward Price EarningsACA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ACA is valued cheaply inside the industry as 81.82% of the companies are valued more expensively.
  • ACA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ACA is cheaper than 87.27% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.14
EV/EBITDA 12.93
ACA Per share dataACA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.71
PEG (5Y)1.92
EPS Next 2Y11.17%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.18%, ACA is not a good candidate for dividend investing.
  • ACA's Dividend Yield is a higher than the industry average which is at 0.13.
  • Compared to an average S&P500 Dividend Yield of 1.82, ACA's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.18%

5.2 History

  • The dividend of ACA decreases each year by -0.48%.
  • ACA has been paying a dividend for over 5 years, so it has already some track record.
  • As ACA did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)-0.48%
Div Incr Years0
Div Non Decr Years5
ACA Yearly Dividends per shareACA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15

5.3 Sustainability

  • ACA pays out 6.66% of its income as dividend. This is a sustainable payout ratio.
DP6.66%
EPS Next 2Y11.17%
EPS Next 3YN/A
ACA Yearly Income VS Free CF VS DividendACA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
ACA Dividend Payout.ACA Dividend Payout, showing the Payout Ratio.ACA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ARCOSA INC

NYSE:ACA (3/3/2026, 3:20:35 PM)

109.96

+1.34 (+1.23%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)02-26
Earnings (Next)05-04
Inst Owners94.81%
Inst Owner Change-3.23%
Ins Owners1.8%
Ins Owner Change2.68%
Market Cap5.39B
Revenue(TTM)N/A
Net Income(TTM)148.60M
Analysts84.44
Price Target125.66 (14.28%)
Short Float %1.81%
Short Ratio3.59
Dividend
Industry RankSector Rank
Dividend Yield 0.18%
Yearly Dividend0.2
Dividend Growth(5Y)-0.48%
DP6.66%
Div Incr Years0
Div Non Decr Years5
Ex-Date04-15
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.63%
Min EPS beat(2)15.61%
Max EPS beat(2)17.65%
EPS beat(4)3
Avg EPS beat(4)38.79%
Min EPS beat(4)-40.32%
Max EPS beat(4)162.24%
EPS beat(8)7
Avg EPS beat(8)30.62%
EPS beat(12)11
Avg EPS beat(12)32.12%
EPS beat(16)15
Avg EPS beat(16)40.53%
Revenue beat(2)1
Avg Revenue beat(2)-1.27%
Min Revenue beat(2)-3.72%
Max Revenue beat(2)1.18%
Revenue beat(4)2
Avg Revenue beat(4)-1.29%
Min Revenue beat(4)-4.44%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.83%
Revenue beat(12)7
Avg Revenue beat(12)0.53%
Revenue beat(16)11
Avg Revenue beat(16)1.99%
PT rev (1m)-0.48%
PT rev (3m)2.81%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.56%
EPS NY rev (1m)-0.3%
EPS NY rev (3m)4.09%
Revenue NQ rev (1m)-0.29%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)0.17%
Valuation
Industry RankSector Rank
PE 24.6
Fwd PE 22.56
P/S 1.9
P/FCF 17.14
P/OCF 11.49
P/B 2.09
P/tB 5.87
EV/EBITDA 12.93
EPS(TTM)4.47
EY4.07%
EPS(NY)4.88
Fwd EY4.43%
FCF(TTM)6.42
FCFY5.83%
OCF(TTM)9.57
OCFY8.7%
SpS57.77
BVpS52.71
TBVpS18.73
PEG (NY)2.71
PEG (5Y)1.92
Graham Number72.81
Profitability
Industry RankSector Rank
ROA 2.94%
ROE 5.75%
ROCE 6.5%
ROIC 4.99%
ROICexc 5.24%
ROICexgc 8.62%
OM 10.27%
PM (TTM) 5.25%
GM 21.61%
FCFM 11.11%
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
ROICexc(3y)4.17%
ROICexc(5y)4.21%
ROICexgc(3y)7.17%
ROICexgc(5y)7.33%
ROCE(3y)5.21%
ROCE(5y)5.27%
ROICexgc growth 3Y4.01%
ROICexgc growth 5Y-10.09%
ROICexc growth 3Y4.98%
ROICexc growth 5Y-11.63%
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 5.03
Debt/EBITDA 3.04
Cap/Depr 68.36%
Cap/Sales 5.46%
Interest Coverage 250
Cash Conversion 90.74%
Profit Quality 211.71%
Current Ratio 2.02
Quick Ratio 1.3
Altman-Z 2.43
F-Score5
WACC9.49%
ROIC/WACC0.53
Cap/Depr(3y)104.81%
Cap/Depr(5y)89.02%
Cap/Sales(3y)7.45%
Cap/Sales(5y)6.15%
Profit Quality(3y)128.08%
Profit Quality(5y)133.99%
High Growth Momentum
Growth
EPS 1Y (TTM)48.5%
EPS 3Y26.66%
EPS 5Y12.78%
EPS Q2Q%150%
EPS Next Y9.06%
EPS Next 2Y11.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.58%
Revenue Next Year5.18%
Revenue Next 2Y5.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y48.65%
EBIT growth 3Y20.99%
EBIT growth 5Y5.01%
EBIT Next Year135.6%
EBIT Next 3Y38.45%
EBIT Next 5YN/A
FCF growth 1Y5015.62%
FCF growth 3Y56.55%
FCF growth 5Y2.7%
OCF growth 1Y146.35%
OCF growth 3Y44.47%
OCF growth 5Y6.95%

ARCOSA INC / ACA FAQ

Can you provide the ChartMill fundamental rating for ARCOSA INC?

ChartMill assigns a fundamental rating of 5 / 10 to ACA.


Can you provide the valuation status for ARCOSA INC?

ChartMill assigns a valuation rating of 4 / 10 to ARCOSA INC (ACA). This can be considered as Fairly Valued.


How profitable is ARCOSA INC (ACA) stock?

ARCOSA INC (ACA) has a profitability rating of 5 / 10.


What is the valuation of ARCOSA INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ARCOSA INC (ACA) is 24.6 and the Price/Book (PB) ratio is 2.09.


How financially healthy is ARCOSA INC?

The financial health rating of ARCOSA INC (ACA) is 5 / 10.